California Surgical Mesh Lawyers Offer Free Case Review After FDA Issues Warning Regarding Serious Complications from Transvaginal Placement of of Surgical Mesh in Repair of Pelvic Organ Prolapse
Surgical mesh is a medical device that is used to treat Pelvic Organ Prolapse (POP). A transvaginal mesh implant supports weakened pelvic muscles and sagging pelvic organs. While not going as far as to issue a transvaginal mesh recall, the FDA recently warned surgeons and patients against the use of mesh to treat POP. A 2011 FDA Warning regarding the transvaginal placement of surgical mesh to treat pelvic organ prolapse and stress urinary incontinence (which followed an initial vaginal mesh warning issued in 2008) outlined severe transvaginal mesh problems caused by the erosion of the mesh through the vagina. This circumstance can cause debilitating pain, bleeding, organ damage, urinary problems and recurrent prolapse. The FDA's warning stated that this condition is not uncommon and that there is no clear evidence that mesh offers any surgical advantage over other methods.
The implantation of surgical mesh to treat pelvic organ prolapse is considered a permanent procedure in that, once implanted, the mesh can never be fully removed. Women who have encountered mesh problems may continue to suffer the effects for the rest of their lives. Many women have been required to undergo multiple – up to ten – repair surgeries in order to extract pieces of mesh. For a medical device that offers no clear advantage over regular stitches, surgical mesh is proving to be a seriously flawed medical product, especially with transvaginal placement. Nine separate companies manufacture transvaginal mesh, all of which have proved to have side effects for far too many users. These companies, including Johnson & Johnson (having faced one medical device recall after another in recent years), advertise the use of mesh to treat POP as the latest and best technological advance in urogynecology. The 2011 FDA Safety Warning reveals that transvaginal mesh placement is more harmful than it is beneficial.
Since 2008, the numbers of women reporting side effects from mesh have risen substantially. In the last three years (2008-2010), the number of pelvic mesh complaints has tripled over the preceding three years, half of which were the result of failed POP repair.
This website offers comprehensive information about vaginal mesh and why it's used to treat pelvic organ prolapse; when it was known that transvaginal implantation of mesh was harmful; where to find details about the FDA transvaginal mesh warning and the rights you may have if you or a family member has suffered from surgical mesh side effects.